Can propranolol (at doses ≥80 mg per day) cause night sweats in a 43‑year‑old woman with an ovarian cyst and uterine leiomyoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Propranolol Cause Night Sweats?

Yes, propranolol can cause night sweats and sleep disturbances, which are recognized side effects of beta-blocker therapy, though night sweats specifically are not a commonly emphasized adverse effect in the primary literature for propranolol.

Evidence from Guidelines and Drug Labels

The FDA drug label for propranolol 1 does not specifically list night sweats as a side effect. However, multiple clinical guidelines consistently document sleep disturbances as a common adverse effect of propranolol therapy 2, 3, 2. The 2003 ACC/ESC consensus document on hypertrophic cardiomyopathy explicitly states that "potential side effects include fatigue, impotence, sleep disturbances, and chronotropic incompetence" 4.

Mechanism and Clinical Context

Beta-blockers affect thermoregulation and sweating patterns. Research demonstrates that propranolol (at 160 mg/day) causes increased total sweat production during physical stress, particularly during the initial phases of activity 5. This enhanced sweating response is transient but measurable, suggesting propranolol can alter normal sweating mechanisms.

Important Distinction

While propranolol was studied for treating menopausal hot flushes (and found ineffective 6), this does not mean it cannot cause sweating or night sweats as a side effect. These are separate physiological phenomena:

  • Hot flushes are vasomotor events related to estrogen deficiency
  • Drug-induced sweating/night sweats result from altered autonomic regulation

Clinical Considerations for Your Patient

For a 43-year-old woman on ≥80 mg propranolol daily with ovarian cyst and uterine leiomyoma:

Key points to evaluate:

  • Sleep disturbances are a documented common side effect of propranolol that could manifest as night sweats 2, 3, 4
  • The dose (≥80 mg/day) is within the therapeutic range where side effects occur
  • Alternative causes must be excluded, particularly given her gynecologic conditions:
    • Perimenopausal vasomotor symptoms (common at age 43)
    • Thyroid dysfunction (propranolol can mask hyperthyroid symptoms)
    • Infection or other medical conditions 7

Differential diagnosis priorities:

  1. Evaluate menopausal status (FSH, estradiol if clinically indicated)
  2. Check thyroid function (TSH, free T4) 7
  3. Consider propranolol as contributory if other causes excluded
  4. Note that uterine leiomyomas themselves do not cause night sweats 8

Management Algorithm

If propranolol is suspected:

  • Consider switching to a cardioselective beta-blocker (atenolol, metoprolol) which may have fewer CNS and thermoregulatory effects 4, 9
  • Cardioselective agents are preferred in some guidelines specifically to minimize non-cardiac side effects 9
  • Do not abruptly discontinue; taper gradually over 1-3 weeks to prevent rebound tachycardia 2

The night sweats are more likely multifactorial in a perimenopausal woman, with propranolol potentially contributing to or exacerbating sleep disturbances that manifest as nocturnal symptoms.

References

Research

Effect of beta-adrenoceptor blockade on thermoregulation during prolonged exercise.

Journal of applied physiology (Bethesda, Md. : 1985), 1985

Research

A study of the effectiveness of propranolol in menopausal hot flushes.

British journal of obstetrics and gynaecology, 1978

Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.